TG Therapeutics, Inc. (TGTX)
TGTX price $53.15 -0.05 -0.09%
- Ticker
- TGTX
- Price
- $53.15
- Change
- -0.05 -0.09%
- Market cap
- $8.14B
- P/E
- 17.47
- Forward P/E
- 53.17
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 50
Based in New York City and established in 1993, TG Therapeutics, Inc. is a biopharmaceutical company that has advanced to the commercial stage. Its core mission revolves around the acquisition, advancement, and marketing of novel therapeutic solutions. The company's focus areas specifically include B-cell related cancers (malignancies) and various autoimmune disorders. Among its significant investigational…